{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:55:43Z","timestamp":1765871743886,"version":"3.48.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary microvascular dysfunction (CMD) is a recognized cause of ischaemia in patients without obstructive coronary artery disease; however, it may also present as a clinical manifestation of light-chain (AL) amyloidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 67-year-old woman presented with exertional chest discomfort. Coronary computed tomography suggested coronary artery stenosis, and the clinical presentation initially indicated angina pectoris. However, coronary angiography revealed no obstructive lesions. An invasive physiological assessment showed a severely reduced coronary flow reserve (1.0) and a markedly elevated index of microvascular resistance (IMR, 77), findings that were consistent with CMD. The initiation of a beta-blocker worsened these symptoms and increased the B-type natriuretic peptide level. In further evaluations, a monoclonal IgG-\u03ba protein was identified, technetium-99m pyrophosphate scintigraphy was negative, and bone marrow biopsy showed amyloid deposits. Endomyocardial biopsy confirmed AL-type cardiac amyloidosis. The patient was referred to the Department of Hematology, and chemotherapy was initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The present case suggests that CMD with a markedly elevated IMR is an early sign of AL amyloidosis. An awareness of this relationship may help avoid inappropriate therapies, such as beta-blockers, and enable an earlier diagnosis and treatment<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf631","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T12:39:22Z","timestamp":1764506362000},"source":"Crossref","is-referenced-by-count":0,"title":["Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6006-0308","authenticated-orcid":false,"given":"Ryo","family":"Bando","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences , 3-18-15, Kuramoto-chou, Tokushima 770-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences , 3-18-15, Kuramoto-chou, Tokushima 770-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneyuki","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences , 3-18-15, Kuramoto-chou, Tokushima 770-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ise","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences , 3-18-15, Kuramoto-chou, Tokushima 770-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences , 3-18-15, Kuramoto-chou, Tokushima 770-8503 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2025121602515184400_ytaf631-B1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"2025121602515184400_ytaf631-B2","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2025121602515184400_ytaf631-B3","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"2025121602515184400_ytaf631-B4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2025121602515184400_ytaf631-B5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025121602515184400_ytaf631-B6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.carrev.2025.01.012","article-title":"Coronary microvascular dysfunction endotypes: IMR tips and tricks","volume":"71","author":"Verma","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"key":"2025121602515184400_ytaf631-B7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1054-8807(94)00023-K","article-title":"Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases","volume":"4","author":"Crotty","year":"1995","journal-title":"Cardiovasc Pathol"},{"key":"2025121602515184400_ytaf631-B8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/his.12793","article-title":"Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases","volume":"68","author":"Larsen","year":"2016","journal-title":"Histopathology"},{"key":"2025121602515184400_ytaf631-B9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4244\/EIJV5I8A158","article-title":"Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis","volume":"5","author":"Melikian","year":"2010","journal-title":"EuroIntervention"},{"key":"2025121602515184400_ytaf631-B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCINTERVENTIONS.113.000953","article-title":"Thermodilution-derived coronary microvascular resistance and flow reserve in patients with cardiac syndrome X","volume":"7","author":"Luo","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"2025121602515184400_ytaf631-B11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4244\/EIJV9I9A181","article-title":"Reference interval for the index of coronary microvascular resistance","volume":"9","author":"Solberg","year":"2014","journal-title":"EuroIntervention"},{"key":"2025121602515184400_ytaf631-B12","doi-asserted-by":"crossref","first-page":"ehae666.1824","DOI":"10.1093\/eurheartj\/ehae666.1824","article-title":"Increased index of microcirculatory resistance, capillary rarefaction, elevated troponin levels, and their association with transthyretin amyloidosis cardiomyopathy","volume":"45","author":"Suiko","year":"2024","journal-title":"Eur Heart J"},{"key":"2025121602515184400_ytaf631-B13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jacc.2019.11.045","article-title":"Prognostic value of the index of microcirculatory resistance over serum biomarkers in cardiac amyloidosis","volume":"75","author":"Choi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025121602515184400_ytaf631-B14","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza","year":"2010","journal-title":"Circulation"},{"key":"2025121602515184400_ytaf631-B15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2015","journal-title":"Heart Fail Rev"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf631\/65675696\/ytaf631.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/12\/ytaf631\/65675696\/ytaf631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/12\/ytaf631\/65675696\/ytaf631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:52:03Z","timestamp":1765871523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf631\/8363234"}},"subtitle":[],"editor":[{"given":"Helle","family":"S\u00f8holm","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Albert","family":"Gakayavich","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Ana","family":"Devesa","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf631","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,27]]},"article-number":"ytaf631"}}